Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PTC Therapeutics Q2 EPS $(0.83) Beats $(0.98) Estimate, Sales $178.88M Beat $171.46M Estimate

Author: Benzinga Newsdesk | August 07, 2025 04:02pm
PTC Therapeutics (NASDAQ:PTCT) reported quarterly losses of $(0.83) per share which beat the analyst consensus estimate of $(0.98) by 15.65 percent. This is a 35.66 percent increase over losses of $(1.29) per share from the same period last year. The company reported quarterly sales of $178.88 million which beat the analyst consensus estimate of $171.46 million by 4.33 percent. This is a 4.19 percent decrease over sales of $186.70 million the same period last year.

Posted In: PTCT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist